Suscribete

New Cancer Immunotherapy Helps Patients with Metastatic Melanoma Live Longer

A significant new immunotherapy, created by CRI Scientific Advisory Council Associate Director James P. Allison, Ph.D, is...

First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy

CRI celebrates yesterday’s announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food...

Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response

A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool...

2010 Grace Award Winners Announced

CRI announced today that it will present fashion designer Michael Kors and GlaxoSmithKline CEO Andrew Witty with...

CT45, an Unexpected Link Between Hodgkin Lymphoma and Reproductive Germ Cells

In a paper published in the Proceedings of the National Academy of Sciences earlier this month, the...

Targeting Normal Cells in Tumors Slows Cancer Growth

CRI-funded scientists and their colleagues demonstrate that targeting normal cells that surround cancer cells within and around...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.